Admission Phenotype Clarifies the Apparent Prognostic Contrast Between TOAST Etiologic Subtypes in Large‐Core Anterior‐Circulation Large‐Vessel Occlusion
CNS Neuroscience & Therapeutics · 2026-07 · 32 (7)
DOI: 10.1002/cns.71029 ↗Kurz gefasst
Kontrollierte klinische Studie in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 13.07.2026. Verfasst von Chengsong Yue und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, No. 924 Hospital of Joint Logistic Support Force of Chinese PLA, GuangXi, China. Hauptthemen laut MEDLINE: Atherosclerosis, Phenotype, Stroke. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xinqiao Hospital, Army Medical University, through the Discipline Talent Construction Special Project.
Abstract (Originalsprache)
Objective
In large‐core anterior‐circulation large‐vessel occlusion (LVO), differing admission clinical‐imaging profiles complicate interpretation of prognostic differences between large‐artery atherosclerosis (LAA) and cardioembolism (CE). We assessed whether these differences persisted after adjustment and whether endovascular thrombectomy (EVT)–outcome associations differed by etiology.
Methods
We analyzed 631 patients with Alberta Stroke Program Early CT Score (ASPECTS) ≤ 5 from the 38‐center MAGIC registry; 404 underwent EVT plus medical therapy and 227 received medical therapy alone. The primary outcome was 90‐day modified Rankin Scale (mRS) 0–3. Mixed‐effects models assessed etiology–outcome associations and treatment‐by‐etiology interaction. Among EVT‐treated patients, Shapley decomposition quantified domain contributions to attenuation of the LAA–CE contrast.
Results
Among EVT‐treated patients, higher crude odds of mRS 0–3 with LAA (OR 1.59, 95% CI 1.05–2.42) were substantially attenuated after adjustment (aOR 0.92, 95% CI 0.53–1.59). No adjusted LAA–CE contrast was evident with medical therapy alone (aOR 1.12, 95% CI 0.47–2.65). In a separate fixed‐effects decomposition model, the absolute log‐odds contrast was attenuated by 96.2% after inclusion of measured pretreatment domains, with imaging/collateral features, demographics, and stroke severity contributing most. For the secondary mRS 0–2 outcome, adjusted odds favored CE (aOR 0.46, 95% CI 0.25–0.84). No treatment‐by‐etiology interaction was detected ( p = 0.944).
Interpretation
Admission clinical‐imaging phenotype clarified the apparent LAA–CE prognostic contrast and may help reconcile discordant findings across EVT cohorts. These findings reinforce established clinical‐imaging criteria as the basis for hyperacute EVT selection rather than LAA versus CE etiology alone. Trial Registration Chinese Clinical Trial Registry ( ChiCTR.org.cn ); ChiCTR2100051664; https://www.chictr.org.cn/
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, No. 924 Hospital of Joint Logistic Support Force of Chinese PLA, GuangXi, China.
- Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
- Department of Neurology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
ORCID-Profile: Chengsong Yue, Shihai Yang, Xiaolei Shi, Jiaxing Song, Wenjie Zi, Rongzong Li
Förderung
- Xinqiao Hospital, Army Medical University, through the Discipline Talent Construction Special Project
Zitieren
APA
Yue, C., Yang, S., Hou, X., Ma, J., Xu, X., Shi, X., Li, L., Yang, J., Guo, C., Song, J., Zi, W., & Li, R. (2026). Admission Phenotype Clarifies the Apparent Prognostic Contrast Between TOAST Etiologic Subtypes in Large‐Core Anterior‐Circulation Large‐Vessel Occlusion. CNS Neuroscience & Therapeutics, 32(7). https://doi.org/10.1002/cns.71029
Vancouver
Yue C, Yang S, Hou X, Ma J, Xu X, Shi X, et al. Admission Phenotype Clarifies the Apparent Prognostic Contrast Between TOAST Etiologic Subtypes in Large‐Core Anterior‐Circulation Large‐Vessel Occlusion. CNS Neuroscience & Therapeutics. 2026;32(7). doi:10.1002/cns.71029
BibTeX
@article{Yue2026,
author = {Yue, Chengsong and Yang, Shihai and Hou, Xiongxiong and Ma, Jingfu and Xu, Xu and Shi, Xiaolei and Li, Linyu and Yang, Jie and Guo, Changwei and Song, Jiaxing and Zi, Wenjie and Li, Rongzong},
title = {Admission Phenotype Clarifies the Apparent Prognostic Contrast Between TOAST Etiologic Subtypes in Large‐Core Anterior‐Circulation Large‐Vessel Occlusion},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {7},
doi = {10.1002/cns.71029}
}
EUVIMED